Cross icon
Contact us
March 3, 2022

4P004 phase II in silico simulation

4P-Pharma  signs a partnership with QuantHealth, a data science start-up, to conduct in silico clinical trials of its lead drug candidates.​

We are pleased to announce that this partnership will start with 4P004 phase II in-silico simulation, which will significantly increase our clinical trial’s probability of success while maximizing its target population.​

For more information, please follow this link

See the original article